Atovaquone Oral Suspension — Class I drug recall D-0772-2021
Terminated recall by KVK-Tech, Inc., reported 2021-09-01, distributed nationwide. Temperature abuse: the firm received customer complaints of unusual grittiness in the product.
| Recall number | D-0772-2021 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | KVK-Tech, Inc., Newtown, PA, United States |
| Recall initiated | 2021-07-02 |
| Classified | 2021-08-26 |
| Reported by FDA | 2021-09-01 |
| Terminated | 2022-05-23 |
| Distributed | Nationwide (US) |
| Quantity | 1,692 bottles |
| Reason classes | temperature control |
| NDC | 10702-0223, 10702-0223-21 |
| Lot numbers | 16653A, 16654A |
| Expiration dates | 2022-12 |
Product
Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21.
Reason for recall
Temperature abuse: the firm received customer complaints of unusual grittiness in the product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0772-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.